Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04837196
Status:
COMPLETED
Last Update Posted:
2024-07-01
First Post:
2021-04-07
Brief Title:
Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen
Sponsor:
Organization:
Astellas Pharma Inc